Natural product-based nanomedicine: recent advances and issues for the treatment of Alzheimer's disease

Alzheimer's disease (AD) affects the elderly and is characterized by progressive neurodegeneration caused by different pathologies. The most significant challenges in treating AD include the inability of medications to reach the brain because of its poor solubility, low bioavailability, and the...

Full description

Bibliographic Details
Main Authors: Choy, Ker Woon, Wong, Kah Hui, Abas, Razif, Haron, Muhammad Huzaimi, Das, Srijit, Teoh Seong, Lin
Format: Article
Published: Bentham Science Publishers 2022
_version_ 1825937444513513472
author Choy, Ker Woon
Wong, Kah Hui
Abas, Razif
Haron, Muhammad Huzaimi
Das, Srijit
Teoh Seong, Lin
author_facet Choy, Ker Woon
Wong, Kah Hui
Abas, Razif
Haron, Muhammad Huzaimi
Das, Srijit
Teoh Seong, Lin
author_sort Choy, Ker Woon
collection UPM
description Alzheimer's disease (AD) affects the elderly and is characterized by progressive neurodegeneration caused by different pathologies. The most significant challenges in treating AD include the inability of medications to reach the brain because of its poor solubility, low bioavailability, and the presence of the blood-brain barrier (BBB). Additionally, current evidence suggests the disruption of BBB plays an important role in the pathogenesis of AD. One of the critical challenges in treating AD is the ineffective treatments and their severe adverse effects. Nanotechnology offers an alternative approach to facilitate the treatment of AD by overcoming the challenges in drug transport across the BBB. Various nanoparticles (NP) loaded with natural products were reported to aid in drug delivery for the treatment of AD. The nano-sized entities of NP are great platforms for incorporating active materials from natural products into formulations that can be delivered effectively to the intended action site without compromising the material's bioactivity. The review highlights the applications of medicinal plants, their derived components, and various nanomedicinebased approaches for the treatment of AD. The combination of medicinal plants and nanotechnology may lead to new theragnostic solutions for the treatment of AD in the future.
first_indexed 2024-03-06T10:59:35Z
format Article
id upm.eprints-94337
institution Universiti Putra Malaysia
last_indexed 2024-03-06T10:59:35Z
publishDate 2022
publisher Bentham Science Publishers
record_format dspace
spelling upm.eprints-943372023-04-05T02:41:35Z http://psasir.upm.edu.my/id/eprint/94337/ Natural product-based nanomedicine: recent advances and issues for the treatment of Alzheimer's disease Choy, Ker Woon Wong, Kah Hui Abas, Razif Haron, Muhammad Huzaimi Das, Srijit Teoh Seong, Lin Alzheimer's disease (AD) affects the elderly and is characterized by progressive neurodegeneration caused by different pathologies. The most significant challenges in treating AD include the inability of medications to reach the brain because of its poor solubility, low bioavailability, and the presence of the blood-brain barrier (BBB). Additionally, current evidence suggests the disruption of BBB plays an important role in the pathogenesis of AD. One of the critical challenges in treating AD is the ineffective treatments and their severe adverse effects. Nanotechnology offers an alternative approach to facilitate the treatment of AD by overcoming the challenges in drug transport across the BBB. Various nanoparticles (NP) loaded with natural products were reported to aid in drug delivery for the treatment of AD. The nano-sized entities of NP are great platforms for incorporating active materials from natural products into formulations that can be delivered effectively to the intended action site without compromising the material's bioactivity. The review highlights the applications of medicinal plants, their derived components, and various nanomedicinebased approaches for the treatment of AD. The combination of medicinal plants and nanotechnology may lead to new theragnostic solutions for the treatment of AD in the future. Bentham Science Publishers 2022-03-25 Article PeerReviewed Choy, Ker Woon and Wong, Kah Hui and Abas, Razif and Haron, Muhammad Huzaimi and Das, Srijit and Teoh Seong, Lin (2022) Natural product-based nanomedicine: recent advances and issues for the treatment of Alzheimer's disease. Current Neuropharmacology, 20 (8). pp. 1498-1518. ISSN 1570-159X; ESSN: 1875-6190 https://www.eurekaselect.com/article/119503 10.2174/1570159X20666211217163540
spellingShingle Choy, Ker Woon
Wong, Kah Hui
Abas, Razif
Haron, Muhammad Huzaimi
Das, Srijit
Teoh Seong, Lin
Natural product-based nanomedicine: recent advances and issues for the treatment of Alzheimer's disease
title Natural product-based nanomedicine: recent advances and issues for the treatment of Alzheimer's disease
title_full Natural product-based nanomedicine: recent advances and issues for the treatment of Alzheimer's disease
title_fullStr Natural product-based nanomedicine: recent advances and issues for the treatment of Alzheimer's disease
title_full_unstemmed Natural product-based nanomedicine: recent advances and issues for the treatment of Alzheimer's disease
title_short Natural product-based nanomedicine: recent advances and issues for the treatment of Alzheimer's disease
title_sort natural product based nanomedicine recent advances and issues for the treatment of alzheimer s disease
work_keys_str_mv AT choykerwoon naturalproductbasednanomedicinerecentadvancesandissuesforthetreatmentofalzheimersdisease
AT wongkahhui naturalproductbasednanomedicinerecentadvancesandissuesforthetreatmentofalzheimersdisease
AT abasrazif naturalproductbasednanomedicinerecentadvancesandissuesforthetreatmentofalzheimersdisease
AT haronmuhammadhuzaimi naturalproductbasednanomedicinerecentadvancesandissuesforthetreatmentofalzheimersdisease
AT dassrijit naturalproductbasednanomedicinerecentadvancesandissuesforthetreatmentofalzheimersdisease
AT teohseonglin naturalproductbasednanomedicinerecentadvancesandissuesforthetreatmentofalzheimersdisease